CNS Co (TSE:4076) Research & Development: 円0 Mil (TTM As of Nov. 2025)


TSE:4076 CNS Co Ltd TSE:4076
85 GF Score
Price 円1,741.00
GF Value 円1,971.09
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is CNS Co Research & Development?

CNS Co TSE:4076 +1.81% 85 Research & Development is 円0 Mil as of Nov. 2025. GuruFocus rates TSE:4076 with a GF Score™ of 85/100 and a GF Value™ of 円1,971.09 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. CNS Co's Research & Development for the three months ended in Nov. 2025 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Nov. 2025 was 円0 Mil.


CNS Co  (TSE:4076) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


CNS Co Research & Development Related Terms


CNS Co Research & Development Historical Data

* Premium members only.

The historical data trend for CNS Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CNS Co Research & Development Chart

CNS Co Annual Data
Trend May19 May20 May21 May22 May23 May24 May25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

CNS Co Quarterly Data
Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4076
85GF Score
CNS Co Ltd TSE:4076
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CNS Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Nov. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0 Mil mean?
CNS Co (TSE:4076) has a Research & Development of 円0 Mil as of Nov. 2025. Research and development expense is the total cost for research and development activities. View historical data on CNS Co and its competitors.
Is CNS Co's Research & Development too high?
CNS Co's current Research & Development is 円0 Mil. Overall, CNS Co has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CNS Co's Research & Development compare to IBM and ACN?
CNS Co's Research & Development of 円0 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Software company?
A good Research & Development depends on the Software industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on CNS Co and its competitors. CNS Co's current Research & Development is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CNS Co stock overvalued right now?
Based on GuruFocus' analysis, CNS Co (TSE:4076) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,971.09, compared to a current price of 円1,741.00 — trading 11.7% below its estimated fair value. The current Research & Development is 円0 Mil. CNS Co's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For CNS Co (TSE:4076), the current Research & Development is 円0 Mil as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CNS Co (TSE:4076) Overvalued in 2026?

Based on GuruFocus' analysis, CNS Co stock appears to be undervalued. The current stock price of 円1,741.00 is trading 11.7% below its estimated GF Value™ of 円1,971.09. GuruFocus considers CNS Co to be Modestly Undervalued.

Key valuation signals for TSE:4076:

  • Research & Development: 円0 Mil
  • GF Value™: 円1,971.09 vs. price of 円1,741.00 (11.7% below fair value)
  • GF Score™: 85/100 with 1 warning sign

No single metric tells the full story. See the TSE:4076 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CNS Co Business Description

Address 1-5-5 Ebisu Minami, 9th Floor, JR Ebisu Building, Shibuya-ku, Tokyo, JPN, 150-0022
CNS Co Ltd is an information technology solutions company engaged in providing system engineering services. The company offers various solutions to its clients such as consulting services related to digital transformation, data analysis solutions, business system integration, and the implementation, construction, and operation of optimal system infrastructure.
85GF Score

Get the complete analysis for TSE:4076

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,741.00
Price
円1,971.09
GF Value